Physician profile
Anthony E Mega
NPI 1457309858
$64,729.92
in general payments reported to CMS, 2019-2025
13 companies · $70.68 in 2025
The $70.68 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $12K · 2021: $11K · 2022: $16K · 2023: $6,947 · 2024: $106 · 2025: $70.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,929 · Consulting Fee: $900 · Food and Beverage: $269 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,929.00 |
| Consulting Fee | $900.00 |
| Food and Beverage | $268.65 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $51,838.18 | 2019-2023 | Opdivo |
| Astellas Pharma US INC | $10,365.50 | 2020-2021 | |
| Dendreon Pharmaceuticals LLC | $1,750.00 | 2020 | |
| Celgene Corporation | $500.00 | 2022 | |
| Comsort, INC | $100.00 | 2019 | |
| Roche Diagnostics Corporation | $90.46 | 2024 | |
| Daiichi Sankyo INC. | $44.98 | 2025 | Enhertu |
| Merck Sharp & Dohme LLC | $25.70 | 2025 | Welireg |
| Tempus Ai, INC | $15.10 | 2024 | Xt Cdx |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Mega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.